12:00 AM
 | 
May 20, 2013
 |  BC Week In Review  |  Company News  |  Other News

Santhera ophthalmic, musculoskeletal news

Santhera said the majority of shareholders at its annual shareholders' meeting supported the company's proposed business continuation and evaluation of all strategic options. In line with the proposal, Santhera said it is exploring product licensing or sale and the possibility of a merger and continues to implement...

Read the full 214 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >